Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.29%
1,043.71
+3.02
+0.29%
1,040.691,048.261,057.851,040.36
SIXC
Communications
SIXC
Communications
SIXC
+0.82%
564.95
+4.59
+0.82%
560.36560.36568.72560.36
SIXE
Energy
SIXE
Energy
SIXE
-1.04%
1,303.96
-13.73
-1.04%
1,317.691,324.291,335.361,300.61
SIXI
Industrials
SIXI
Industrials
SIXI
-1.61%
1,581.04
-25.87
-1.61%
1,606.911,611.511,621.751,575.38
SIXM
Financials
SIXM
Financials
SIXM
+1.10%
596.77
+6.49
+1.10%
590.28592.25601.18592.25
SIXR
Staples
SIXR
Staples
SIXR
+0.08%
828.67
+0.69
+0.08%
827.98828.20835.94826.16
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.43%
197.88
+0.84
+0.43%
197.04197.04200.54197.04
SIXT
Technology
SIXT
Technology
SIXT
-1.86%
2,569.52
-48.68
-1.86%
2,618.202,638.492,649.452,552.55
SIXU
Utilities
SIXU
Utilities
SIXU
+0.66%
930.76
+6.10
+0.66%
924.66929.51938.99927.44
SIXV
Health care
SIXV
Health care
SIXV
+0.36%
1,454.81
+5.22
+0.36%
1,449.591,453.441,462.731,451.18
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.03%
2,136.17
-0.72
-0.03%
2,136.892,149.922,166.642,126.96
JNJ:NYSE
Johnson & Johnson
$242.49
+0.85%
(+2.04) 1D
$242.49
0.00% (0.00)
After hours
Closed: Mar 30, 4:00:03 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for JNJ...
Open
$243.49
High
$244.21
Low
$240.51
Mkt. cap
584.06B
Avg. vol.
8.63M
Volume
7.24M
Dividend
2.14%
Quarterly dividend
$1.30
Ex dividend date
Feb 24, 2026
P/E ratio
21.19
52-wk high
$251.71
52-wk low
$141.50
EPS
$11.44
Beta
0.34
Shares outstanding
2.41B
No. of employees
138K
News stories
From sources across the web
Profile
Johnson & Johnson is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Its common stock is a component of the Dow Jones Industrial Average, and the company is ranked No. 48 on the 2025 Fortune 500 list of the largest United States corporations. In 2025, the company was ranked 42nd in the Forbes Global 2000. Johnson & Johnson has a global workforce of approximately 138,000 employees who are led by the company's current chairman and chief executive officer, Joaquin Duato. Johnson & Johnson is one of the world's most valuable companies and is one of only two U.S.-based companies that has a prime credit rating of AAA. Johnson & Johnson was founded in 1886 by three brothers, Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson, selling ready-to-use sterile surgical dressings. Wikipedia
About Johnson & Johnson
CEOJoaquin Duato
Employees138K
FoundedJan 1886
HeadquartersNew Brunswick, New Jersey, United States
SectorPharmaceutical industry
Websitejnj.com
Last report
Jan 21, 2026
Fiscal Period
Q4 2025
Normalized EPS / Estimate
2.46/ (2.46 est.)USD
-0.11%miss
Revenue / Estimate
24.56B/ (24.15B est.)USD
+1.72%beat
Fiscal Q4 2025 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
21.89B
23.74B
23.99B
24.56B
Cost of goods sold
7.25B
7.61B
7.29B
7.81B
Cost of revenue
7.25B
7.61B
7.29B
7.81B
Research and development expenses
3.22B
3.52B
3.67B
4.25B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.98B
5.75B
5.78B
6.61B
Operating expense
8.21B
9.27B
9.46B
10.86B
Total operating expenses
15.46B
16.88B
16.75B
18.68B
Operating income
6.44B
6.86B
7.25B
5.89B
Other non operating income
246.00M
207.00M
17.00M
396.00M
EBT including unusual items
13.63B
6.49B
7.49B
4.97B
EBT excluding unusual items
6.87B
6.97B
7.27B
6.03B
Income tax expense
2.63B
954.00M
2.34B
-150.00M
Effective tax rate
19.31%
14.70%
31.24%
-3.02%
Other operating expenses
-
-
-
-
Net income
11.00B
5.54B
5.15B
5.12B
Net profit margin
50.24%
23.32%
21.47%
20.83%
Earnings per share
2.77
2.77
2.80
2.46
Interest and investment income
332.00M
260.00M
227.00M
237.00M
Interest expense
-204.00M
-308.00M
-245.00M
-214.00M
Net interest expenses
128.00M
-48.00M
-18.00M
23.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
8.21B
8.81B
9.02B
7.90B
Gain or loss from assets sale
-75.00M
1.00M
-57.00M
-132.00M
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more